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After a terrorist attack, a signifi cant percentage of the victims 
will suffer posttraumatic stress disorder (PTSD), and depressive 
or anxiety disorders (García-Vera & Sanz, 2016). The review by 
García-Vera, Sanz, and Gutiérrez (2016) found that 30% of the 
direct victims and 23% of those close to the injured or deceased will 
suffer PTSD. In many cases, such disorders will not subside. The 
average rate of spontaneous remission of PTSD for the 10 studies 
on terrorist attacks in the meta-analysis by Morina Wicherts, 
Lobbrecht, and Priebe (2014) was 54.6% after 3.7 years.
Empirical literature on the effi cacy or effectiveness of 
psychological treatments for mental disorders of victims of 
terrorism is very scarce. Five studies have examined their effi cacy 
for PTSD when compared to a waiting list or usual treatment (e.g., 
Difede et al., 2007; Duffy, Gillespie, & Clark, 2007; Gesteira, 
García-Vera, & Sanz, 2017). Their results indicate that trauma-
focused cognitive behavioral therapy (TF-CBT) is effi cacious and 
should be considered the treatment of choice, as it is currently the 
only one with empirical support in victims of terrorism (García-
Vera et al., 2015).
However, the fact of a therapy having of positive effects 
in effi cacy studies does not guarantee that it will be useful 
in standard clinical practice. These studies are carried out 
under the most optimal and controlled conditions possible to 
detect any minimal positive effects attributable to treatment 
(e.g., homogeneous patient samples; random assignment of 
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Abstract Resumen
Background: There are no published studies on the clinical utility of 
psychotherapy in victims of terrorism who suffer emotional disorders 
many years after the attacks. Method: A course of trauma-focused 
cognitive behavioral therapy was administered to 50 victims of terrorist 
attacks that occurred an average of 23 years previously and who presented 
isolated or concurrent posttraumatic stress disorder (PTSD; 74%), major 
depressive disorder (54%), panic disorder (38%), or other anxiety disorders 
(38%). Results: According to an intention-to-treat analysis (N=50), 
these percentages decreased signifi cantly to 24% (PTSD and major 
depression), 16% (panic disorder) and 14% (other anxiety disorders) at 
1-year follow-up. According to a complete data analysis, at posttreatment 
no victims (n=31) still presented major depressive or panic disorder, 
only 3.2% presented PTSD and 9.7% presented other anxiety disorders, 
whereas at 1-year follow-up, no victims presented any disorders (n=22). 
At posttreatment and at the 1-, 3-, 6-month, and 1-year follow-ups, large 
statistically and clinically signifi cant decreases in PTSD, depression, and 
anxiety symptomatology were found (d=1.26 to 2.52 at 1-year follow-up). 
Conclusions: These results suggest that effi cacious treatments for recent 
victims are also useful in the usual clinical practice for victims with very 
long-term emotional disorders.
Keywords: Psychotherapy, effectiveness, emotional disorders, terrorism.
Efectividad de la terapia cognitivo conductual centrada en el trauma 
para víctimas de terrorismo con trastornos emocionales a muy largo 
plazo. Antecedentes: no hay estudios publicados sobre la utilidad clínica 
de la psicoterapia para víctimas del terrorismo con trastornos emocionales 
muchos años después del atentado. Método: se administró terapia cognitivo 
conductual centrada en el trauma a 50 víctimas de atentados ocurridos 
una media de 23 años antes y que presentaban aislada o concurrentemente 
trastorno de estrés postraumático (TEPT; 74%), depresivo mayor (54%), 
de angustia (38%) u otros trastornos de ansiedad (38%). Resultados: 
según un análisis de intención de tratar, esos porcentajes disminuyeron 
signifi cativamente al año a 24% (TEPT y depresión mayor), 16% (trastorno 
de angustia) y 14% (trastornos de ansiedad). Según un análisis con datos 
completos, en el postratamiento ninguna víctima (n=31) presentaba 
ya trastorno depresivo mayor o de angustia y solo un 3,2% TEPT y un 
9,7% otros trastornos de ansiedad, mientras que al año ninguna víctima 
presentaba trastornos (n=22). En el postratamiento y en los seguimientos 
a 1, 3 y 6 meses y al año, hubo descensos en sintomatología de TEPT, 
depresión y ansiedad estadística y clínicamente signifi cativos y grandes 
(d=1.26 a 2.52 al año). Conclusiones: los tratamientos efi caces para 
víctimas recientes también son útiles en la práctica clínica en víctimas 
con trastornos emocionales a muy largo plazo.
Palabras clave: psicoterapia, efectividad, trastornos emocionales, 
terrorismo.
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patients; homogeneously trained therapists who strictly follow 
the treatments). However, by prioritizing internal validity, such 
studies partially sacrifi ce external validity, and it is unclear 
whether their effects are generalizable to the standard practice in 
which a more heterogeneous population receives intervention and 
the treatments are applied fl exibly by heterogeneous clinicians in 
training (García-Vera et al., 2015). Effectiveness studies address 
the clinical usefulness of an intervention that has already proven 
its effi cacy by examining its effects under conditions similar to 
those of standard clinical practice.
Only three group effectiveness studies have been published and, 
although they confi rmed that TF-CBT is also useful in standard 
clinical practice, they were conducted with relatively recent victims 
who had suffered the attack a maximum of 2 months (García Vera 
& Romero Colino, 2004), 10 months (Gillespie et al., 2002), or 
15-24 months previously (Brewin et al., 2008, 2010). We know of 
no studies that have analyzed the effectiveness of TF-CBT or of 
any other psychological or pharmacological therapy with victims 
of terrorism who suffer emotional disorders many years after the 
attacks: 5, 10, or 25 years later. As the emotional disorders of many 
victims do not subside, it is necessary to know the clinical utility 
of treatments for emotional disorders at a very long term. This was 
precisely the main objective of this study in which TF-CBT was 
applied to victims of attacks occurring at least 5 years earlier and 
who were currently suffering from PTSD, anxiety disorder, and/
or depressive disorder.
In addition, of the three studies conducted so far on the 
effectiveness of TF-CBT for victims of terrorism, only one 
examined whether its utility was maintained over time (Brewin 
et al., 2010). Therefore, the present study analyzed the results of 
TF-CBT both at posttreatment and at the follow-ups of one, three, 
six months, and one year.
Method
Participants
 
All the members of the Victims of Terrorism Association 
from Murcia, Extremadura, Valencia, and Galicia were contacted 
and, following a phone screening and a face-to-face diagnostic 
interview, 92 victims were diagnosed with PTSD, anxiety 
disorder, or depressive disorder according to criteria of the DSM-
IV. Of these, four victims were excluded for not being over 18 
years of age or not being a direct or indirect victim of a terrorist 
attack, or for suffering any of the following mental disorders: 
organic brain disorder, substance-induced disorder, disorder due 
to medical illness, mental or developmental retardation, psychotic 
or bipolar disorder, or substance dependence/abuse disorder. Of 
the 88 victims who were offered treatment, 58% had been injured, 
and 26.1% and 15.9% were fi rst-degree relatives of the deceased 
and injured, respectively, in attacks that had occurred an average 
of 23.07 years ago (SD = 8.68 years), and most had received a 
diagnosis of PTSD (69.3%), major depressive disorder (47.7%) 
and/or anxiety disorder (35.2%).
Thirty-eight victims refused to start treatment, 19 dropped out, 
and some victims did not complete all the assessments (between 
one and nine depending on the time of evaluation), so some data 
analyses were performed with all the victims who started treatment 
(intention-to-treat analysis; n=50) and others were performed 
with those who also presented full data at the time of evaluation 
(complete data analysis; n=31 to 20). Therefore, the intention-
to-treat analysis included all the patients who were offered the 
treatment and initiated treatment, regardless of whether they 
dropped out or their treatment adherence. In this type of analysis, 
missing data at posttreatment or follow-ups were replaced with 
the last available measure. For example, when victims had missing 
data at posttreatment about the presence of diagnosable mental 
disorders or their level of psychological symptomatology, it was 
considered conservatively that, at posttreatment, these victims 
continued to have the mental disorders and levels of psychological 
symptomatology that they had presented at pretreatment. As 
shown in Table 1, victims who completed treatment (n=31) and 
those who did not initiate treatment or who dropped out (n=57) 
did not differ signifi cantly in their sociodemographic or clinical 
characteristics, except for increased depressive symptomatology 
among the latter victims (p<.04), a difference that, however, was 
small (d=0.21).
Instruments
– Diagnosis of PTSD and anxiety and depressive disorders: 
Structured Clinical Interview for DSM-IV Axis I Disorders, 
Clinician Version (SCID-I-CV; First, Spitzer, Gibbon, & 
William, 1999).
– Posttraumatic stress symptomatology: PTSD Checklist, 
specifi c version (PCL-S; Weathers, Litz, Herman, Huska, & 
Table 1
Comparison of the Sociodemographic and Clinical Characteristics of Patients 
who completed Therapy and those who rejected it or dropped out
Characteristic
Completers
(n = 31)
Rejecters or 
dropouts
(n = 57)
t / χ2 p
Age (years) 49.3 (12.1) 51.5 (14.5) 0.86 .35
Gender (% of females) 48.4% 40.4% 0.52 .46
Marital status (% of married/living 
with a partner)
67.7% 56.1% 1.12 .28
Education (% of secondary or 
higher)
77.4% 57.9% 3.35 .06
Socioeconomic status (% of low/
low-middle)
12.9% 24.6% 1.67 .19
With children (%) 74.2% 80.7% 0.50 .47
Years after the terrorist attack 23.8 (8.7) 22.6 (8.6) 0.04 .84
Type of victim (%)
– Injured
– Relative of the deceased
– Relative of the injured
64.5%
19.4%
38.7%
52.6%
36.8%
22.8%
1.15
2.88
2.49
.28
.08
.11
Diagnosis (%)
– PTSD
– Major depressive disorder
– Panic disorder
80.6%
48.4%
35.5%
63.2%
47.4%
35.1%
2.88
0.01
0.00
.89
.92
.97
PTSD symptoms (PCL-S) 49.5 (12.5) 47.3 (13.5) 1.70 .19
Depressive symptoms (BDI-II) 21.2 (9.3) 23.6 (12.4) 4.23 .04
Anxiety symptoms (BAI) 20.3 (13.8) 21.9 (12.6) 0.08 .77
Current suicidal thoughts 19.4% 23.2% 0.17 .67
Taking psychotropic medication 45.2% 42.1% 0.70 .78
Note: All values are means (with standard deviations between parentheses) unless 
otherwise indicated
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Keane, 1993). This questionnaire evaluates the symptomatic 
diagnostic criteria of PTSD according to the DSM-IV, and 
extensive scientifi c literature indicates that it has adequate 
indices of reliability and validity in victims of traumatic 
events, including terrorist attacks in Spanish population 
(Vázquez et al., 2006). 
– Depressive and anxiety symptomatology. Beck-II Depression 
Inventory (BDI-II; Beck, Steer, & Brown, 2011) and Beck 
Anxiety Inventory (BAI; Beck & Steer, 2011), respectively. 
The BDI-II presents 21 groups of statements that measure 
the presence and severity of depressive symptoms according 
to the DSM-IV, and the BAI is 21-item instrument that 
evaluates the presence and severity of anxiety symptoms. 
A large amount of scientifi c literature indicates that both 
instruments have adequate psychometric indices in a broad 
range of populations, including the Spanish one (Beck et al., 
2011; Beck & Steer, 2011).
Procedure
 
All the victims underwent an individual pretreatment face-
to-face evaluation with a psychologist who, after obtaining their 
informed consent, administered the tests in this order: SCID-I-
CV, BDI-II, BAI, and PCL-S. The SCID-I-CV was applied fi rst 
because it was assumed that, compared to the questionnaires, 
the interview would, to a greater extent, help to establish a good 
relationship with the participants and because, in addition, the 
primary measure of outcome was the presence of diagnosable 
mental disorders. The order of application of the questionnaires 
followed the order in which depressive, anxiety, and posttraumatic 
stress disorders are evaluated with the SCID-I-CV. In an individual 
session held one week later, each victim was offered information 
about their results and about the voluntary, free psychological 
treatment they could follow. The victims who agreed signed 
an informed consent sheet and began their treatment with the 
psychologist who, in general, was the same one who had evaluated 
them, and then, this psychologist evaluated them at posttreatment 
and at the follow-ups.
Psychological treatment was a TF-CBT program based on the 
prolonged exposure therapy for PTSD of Foa et al. (2007) to which 
had been added cognitive techniques for PTSD and other cognitive 
and cognitive-behavioral techniques for anxiety or depressive 
disorders. The therapy consisted of 16 individual, weekly sessions 
of 60 minutes, although their number and duration was applied 
fl exibly according to the peculiarities of the patient. Among the 31 
patients who completed the treatment, the sessions ranged from 13 
to 20, with an average of 16. Therapy began with psycho-education 
sessions on reactions to trauma and grief and their normalization 
(1st session). The therapy also included anxiety control techniques 
such as training in progressive relaxation and slow breathing (2nd 
and 3rd session), scheduling pleasant activities for depression 
(2nd and 3rd session), and cognitive restructuring techniques for 
negative thoughts and dysfunctional attitudes characteristic of 
PTSD, depression, or anxiety (2nd to 15th session). From 6th session 
to 14th session, the therapy included progressive imaginary and 
live exposure to traumatic memories, including thoughts, objects, 
people, situations, and environments reminiscent of the attack and 
the related traumatic events, and, other anxiety-provoking stimuli 
related to other anxiety disorders. The therapy ended with sessions 
for relapse prevention, maintenance of the achievements, and the 
creation of a new life narrative (15th and 16th session). The most 
important therapeutic strategies and techniques of TF-CBT by 
session can be consulted in Moreno Pérez (2016).
At the end of the last treatment session, the patients completed 
a posttreatment evaluation in which were applied, in this order: 
SCID-I-CV, BDI-II, BAI, and PCL-S. Subsequently, all patients 
were scheduled for individual, face-to-face follow-ups at one 
month, three months, six months, and one year, at which the BDI-
II, BAI, and PCL-S were applied, and, at the one-month and one-
year follow-ups, also the SCID-I-CV.
Initially, the treatment was applied to 64.5% of the patients 
by three psychologists with postgraduate training in clinical 
psychology, taking into account the strategies and techniques of 
Moreno Pérez (2016), but without following a manual or receiving 
specifi c training. Subsequently, the treatment was manualized, 
and another six psychologists with postgraduate training in 
clinical psychology participated in its application, and all nine 
psychologists received specifi c training in this regard.
Data analysis
IBM SPSS Statistics for Windows, version 22.0, was used for 
all statistical analyses, and both intention-to-treat and complete 
data analyses were performed. McNemar tests were performed 
to compare pretreatment prevalence of diagnosable emotional 
disorders with that of other assessment moments.
One-way repeated-measure ANOVAs were performed to 
analyze differences between the assessment moments in the 
symptomatology measurements. In case of signifi cant results 
of these ANOVAs, repeated-measure t-tests were performed to 
compare the pretreatment mean score with the scores of the other 
assessments. Although these parametric tests are robust to non-
compliance with the assumption of normality of the measures, 
and this non-compliance appeared only in some of them, 
nonparametric analyses were also performed: Friedman tests and, 
in case of signifi cant results, Wilcoxon tests.
We calculated percentages of victims who, at the different 
assessment times, scored in the measures of emotional 
symptomatology above the cut-off points, indicating a moderate-
severe or clinically signifi cant symptomatology, and McNemar 
tests were performed to compare pretreatment percentages with 
that of other assessment times.
To examine the infl uence of pharmacotherapy, two-way mixed 
ANOVAs were performed on the symptomatology measures with 
the group of victims (psychotropic vs. no psychotropic medication) 
as a between-subject factor, and the time of assessment (pre, post, 1 
month, 3 months, 6 months, and 1 year) as a within-subject factor, 
since a signifi cant effect of the interaction between the group of 
victims and the assessment time would indicate that reductions 
in symptomatology differed between victims with and without 
medication.
Results
Reducing emotional disorders
 
Table 2 lists the prevalence of emotional disorders at different 
times of evaluation and with different types of analysis. McNemar 
tests were performed to compare pretreatment prevalence with 
that of other evaluation moments. Their results indicated that, both 
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at posttreatment and at the follow-ups, both with the complete data 
analysis and the intention-to-treat data analysis, the prevalence of 
PTSD, major depressive disorder, and panic disorder decreased 
signifi cantly (between 26 and 80 percentage points). For other 
anxiety disorders, the pattern of results also refl ected a signifi cant 
decrease in their prevalence at posttreatment and at the follow-ups, 
although according to the full data analysis, this difference was 
not statistically signifi cant for the one-year prevalence. All other 
reductions were statistically signifi cant and important (between 
18 and 35 percentage points). 
Reducing emotional symptomatology
 
Table 3 presents the mean score obtained by victims in the 
measures of symptomatology of posttraumatic stress, depression, 
and anxiety in the different assessments. Three one-way repeated-
measure ANOVAs revealed signifi cant differences between the 
assessment moments in the symptomatology measurements. 
Therefore, repeated-measure t-tests were performed by comparing 
the pretreatment mean score with the scores of the other 
assessments. The t-test results indicated that the mean score in all 
three types of symptomatology decreased signifi cantly (p<.001) 
at all the evaluations, and, moreover, the reductions were all large, 
with effect sizes between 1.24 and 2.52. For example, at the one-
year follow-up, we found a reduction of more than two standard 
deviations in the posttraumatic stress (d=2.29) and depression 
(d=2.52) symptomatology and more than one standard deviation in 
anxiety symptomatology (d=1.26). The results of nonparametric 
analyses (Friedman tests and, later, Wilcoxon tests) confi rmed the 
signifi cant results obtained with the ANOVAs and t-tests.
Table 2
Prevalence of Emotional Disorders at Pretreatment (Pre), Posttreatment (Post), and One-month (1 month) and One-year (1 year) Follow-Ups
Emotional disorder
Complete data analysis Intention-to-treat analysis
Pre
(n = 31)
Post
(n = 31)
1 month
(n = 30)
1 year
(n = 22)
Pre
(n = 50)
Post
(n = 50)
1 moth
(n = 50)
1 year
(n = 50)
PTSD 80.6 3.2*** 0*** 0*** 74 26*** 24*** 24***
Major depression 48.4 0*** 0** 0*** 54 24*** 24*** 24***
Panic 35.5 0*** 0*** 0* 38 16*** 16*** 16***
Other anxiety disorders 38.7 9.7** 3.3*** 0 38 20** 16*** 14***
Note: All values are percentages. *Signifi cant difference in comparison to pretreatment at p<.05. **Signifi cant difference in comparison to pretreatment at p<.01. ***Signifi cant difference in 
comparison to pretreatment at p<.001
Table 3
Mean Levels of Symptomatology at Pretreatment (Pre), Posttreatment (Post), and Follow-ups (F/u) (Complete Data Analysis)
Symptomatology
Posttreatment
(n = 29)
1 month
(n = 28)
3 months
(n = 22)
6 months
(n= 20)
1 year
(n = 21)
Pre Post d Pre F/u d Pre F/u d Pre F/u d Pre F/u d
PTSD (PCL-S)
49.9
(12.7)
25.5***
(6.9)
2.52
49.1
(13.1)
25.9***
(7.1)
2.29
50.8
(13.4)
25.3***
(7.9)
2.39
49.8
(14.4)
25.2***
(6.6)
2.22
49.8
(13.2)
25.9***
(7.2)
2.29
Depression
(BDI-II)
21.1
(6.7)
6.7***
(5.9)
2.06
19.9
(9.0)
6.9***
(6.5)
1.53
20.9
(8.2)
5.9***
(4.8)
2.37
20.6
(9.2)
5.1***
(5.2)
2.06
21.1
(8.1)
5.9***
(4.8)
2.52
Anxiety (BAI)
20.7
(13.3)
5.2***
(4.1)
2.52
20.4
(13.9)
7.2***
(7.6)
1.24
22.3
(14.5)
4.6***
(3.8)
1.77
20.4
(13.4)
5.6***
(6.2)
1.48
18.8
(12.7)
6.3***
(6.7)
1.26
Note: d= Cohen’s d effect size statistic in comparison to pretreatment. ***Signifi cant difference in comparison to pretreatment at p<.001
Table 4
Percentages of Patients who showed moderate-severe or clinically signifi cant Levels of Symptomatology at Pretreatment (Pre), Posttreatment (Post), and Follow-ups 
(F/u) (Complete Data Analysis)
Symptomatology
Clinically signifi cant 
cut-off point
Posttreatment
(n=29)
1 month
(n=28)
3 months
(n=22)
6 months
(n=20)
1 year
(n=21)
Pre Post Pre F/u Pre F/u Pre F/u Pre F/u
PTSD (PCL-S) > 44 69 0*** 65.5 0*** 63.6 3.2*** 65 0*** 65 0***
Depression (BDI-II) > 19 48.4 3.4*** 42.9 7.1*** 45.5 0** 50 0*** 42.9 0**
Anxiety (BAI) > 15 51.7 3.4*** 50 7.2*** 50 0*** 50 5** 38.1 19.2
Note: All values are percentages unless otherwise indicated. *Signifi cant difference in comparison to pretreatment at p<.05. **Signifi cant difference in comparison to pretreatment at p<.01. 
***Signifi cant difference in comparison to pretreatment at p<.001
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Clinically signifi cant changes in emotional symptomatology
 
Table 4 shows the percentages of victims who, at the different 
assessments, scored in the measures of emotional symptomatology 
above the cut-off points, indicating a moderate-severe or clinically 
signifi cant symptomatology. When comparing the percentages 
at posttreatment and at the follow-ups with the pretreatment 
percentages, using McNemar-tests, the results indicated that all 
the posttreatment and follow-up percentages were signifi cantly 
lower (p<.001) and these reductions were large (between 19 and 69 
percentage points). For example, whereas at pretreatment, 65% and 
42.9% of victims had clinically signifi cant levels of posttraumatic 
stress and depression, respectively, at the one-year follow-up, these 
percentages were reduced to 0%.
Infl uence of pharmacotherapy
 
Of the victims who completed treatment, 45.2% were taking 
psychotropic medication, and the results of three independent-
sample t-tests revealed that victims who also took medication 
tended to show higher scores at pretreatment than victims who 
did not take medication both in PTSD symptomatology (d=0.59) 
and depressive (d=0.50) or anxious symptomatology (d=0.90), 
although only in the latter was the difference signifi cant (p=.032). 
Therefore, using two-way mixed ANOVAs, the reductions in 
symptomatology between victims with and without medication 
were compared with the group of victims (psychotropic vs. no 
psychotropic medication) as a between-subject factor, and the 
time of assessment (pre, post, 1 month, 3 months, 6 months, and 
1 year) as a within-subject factor. Based both on intention-to-treat 
analysis and complete data analysis, the results of these ANOVAs 
showed no signifi cant effect of the interaction between the group 
of victims (psychotropic vs. no psychotropic medication) and the 
assessment time for any of the symptomatology measures (all 
ps>.05). As can be seen in Figure 1, these results indicated that 
there were no statistically signifi cant differences between victims 
who were taking psychotropic medication and those who were 
not in terms of reductions at posttreatment or at the follow-ups in 
symptoms of posttraumatic stress, depression, or anxiety.
Discussion
 
The results of this study confi rm that TF-CBT is clinically 
useful for victims of terrorism suffering from PTSD, as both at 
posttreatment and at the follow-ups, this therapy signifi cantly 
reduced the prevalence and symptomatology of PTSD, both 
statistically and clinically. These results add up to and are 
comparable to those of the few studies that have also established 
the effectiveness of TF-CBT for victims of terrorism with PTSD. 
Gillespie et al. (2002) and Brewin et al. (2008) found that, at 
posttreatment, 73.1% and 87%, respectively, of patients who 
completed TF-CBT had clinically improved their posttraumatic 
stress symptomatology, whereas in this study, this percentage was 
100%. Gillespie et al. and Brewin et al. also found pretreatment-
posttreatment decreases in PTSD symptomatology with effect 
sizes (d) of 2.47 and 1.99–2.53, respectively, whereas in this study, 
the size of the decrease was d=2.52.
Moreover, the results of this study add up to and are comparable to 
those of the only study (Brewin et al., 2010) that established that the 
benefi ts of TF-CBT for victims of terrorism are maintained at long 
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Figure 1. Mean levels of symptomatology at different assessment 
times (pretreatment, posttreatment, and at 1-month, 3-month, 6-month, 
and 1-year follow-ups [f/u]) in victims who were and were not taking 
psychotropic medication (intention-to-treat analysis)
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term, at least, at one-year follow-ups. Brewin et al. found decreases 
at one year in PTSD symptomatology with effect sizes (d ) of 1.5-
1.78, whereas in this study, the decrease at one year was d= 2.29.
However, the most novel aspect with regard to previous studies is 
that the good therapeutic results of this study were obtained in victims 
suffering from PTSD almost 24 years after the attack. Therefore, this 
study demonstrates for the fi rst time that TF-CBT is also effective for 
victims of terrorism suffering from very long-term PTSD.
Another novelty of this study is that it shows that the effectiveness 
of TF-CBT is not limited to PTSD or its symptomatology, but that, 
by adding specifi c techniques for other disorders that victims may 
suffer, this effectiveness extends to depression and anxiety, both 
in terms of statistically and clinically signifi cant reductions of the 
prevalence of anxious and depressive disorders and in the levels of 
symptomatology. For example, 100% (or 55% according to intention-
to-treat analysis) of patients with major depressive disorder and 
100% (or 50%) of patients with anxiety disorder no longer had such 
disorders at the end of therapy or one year after its completion. 
The results of this effectiveness study are comparable to those 
found in cognitive behavioral therapy (CBT) effi cacy studies 
both for victims of terrorism and for victims of other traumatic 
events. The percentage of victims of terrorism showing clinically 
signifi cant improvement of PTSD in TF-CBT effi cacy studies is, 
on average, 50.9% at posttreatment according to an intention-to-
treat analysis (García-Vera et al., 2015), whereas in this study, 
the reductions in PTSD prevalence indicated that 64.8% of the 
PTSD patients had improved at the end of therapy, and 67.5% 
had improved at one year. Cahill, Rothbaum, Resick, and Follette 
(2009) reviewed CBT effi cacy studies for victims with PTSD from 
all kinds of traumatic events. Excluding war veterans, who have 
worse therapeutic outcomes (Bradley, Greene, Russ, Dutra, & 
Westen, 2005), the weighted mean of pretreatment-posttreatment 
effect sizes for victims who completed treatment was 1.73, 
whereas, in this study, it was 2.52. Even in relation to CBT effi cacy 
studies for anxiety or major depressive disorders in all types of 
patients, the results of this study are comparable. In their meta-
analysis on the effi cacy of psychotherapy for major depression, 
Cuijpers et al. (2014) found that, at posttreatment, BDI-II scores 
had decreased an average of 12.7 points with CBT and of 15.1 
points with all kinds of psychotherapies, whereas, in this study, 
this reduction in victims’ scores was of 14.4 points and, at one 
year, of 15.2 points. In their meta-analysis of CBT for anxiety 
disorders, Norton and Price (2007) estimated the effect sizes (d) 
of pretreatment-posttreatment differences at between 1.27 and 
1.80 in anxious symptomatology, whereas, in this study, the effect 
sizes of the pretreatment-posttreatment and pretreatment-follow-
up differences were, respectively, 2.52 and 1.26.
As a result, the outcomes of this study, both in relation to 
PTSD and to depressive or anxiety disorders, are linked to those 
of previous studies showing that the outcomes of CBT and, in 
general, of treatments with empirical evidence through effi cacy 
studies, appear to be as good in standard clinical practice as in 
those effi cacy studies and therefore, we can move empirically-
based treatments from the contexts of research to everyday 
practice (Stewart & Chambless, 2009).
This study has several limitations, some of which refl ect the 
characteristics of an effectiveness study. The absence of a waiting-
list control group makes it very diffi cult to establish with certainty 
that the good outcomes were due to treatment rather than to 
natural recovery processes. However, at least two previous studies 
conducted with victims of terrorism and using experimental 
designs have shown the effectiveness of TF-CBT compared to a 
waiting-list (Difede et al., 2007; Duffy et al., 2007). In addition, as 
the victims of this study had experienced the terrorist attack almost 
24 years ago on average and as most spontaneous recoveries from 
PTSD following a terrorist attack usually occur in the fi rst 4-8 
years (Morina et al., 2014; Neria et al., 2010), it is likely that the 
improvement observed in this study was due to the treatment itself 
and not to spontaneous recovery.
A second limitation is the high number of victims who rejected 
or dropped out of treatment. This latter rate (38%) is higher than 
that of previous studies of the effi cacy and effectiveness of TF-
CBT for victims of terrorism (23.5% and 5.9%, respectively; 
García-Vera et al., 2015) and than that of studies on psychotherapy 
for PTSD in all types of victims (21.1%; Bradley et al., 2005). 
Possibly, both these high rates of drop-out and rejection are related 
to three characteristics of this study inherent to its design. First, the 
treatment was carried out in the capitals of some of the provinces 
of the autonomous communities where the victims lived, but, as 
many lived in other places, it was logical for them to reject or 
drop out of treatment due to travel problems (5.2% rejections and 
10.5% drop-outs) or schedule incompatibility (10.5% rejections 
and 31.5% drop-outs). Second, the victims were offered treatment 
an average of 24 years after the attack, and virtually all of them 
(94.4%) were recruited through an approach procedure, rather 
than responding to their direct request for help. Therefore, it was 
logical for many other victims to reject or drop out of treatment 
because they had already undergone another treatment (21.1% of 
rejections) or did not believe that the effort was worthwhile (13.1% 
of the rejections) or that they would improve (15.8% of the drop-
outs). In any case, increasing the acceptance and adherence to 
treatment among victims of terrorism suffering from emotional 
disorders is a challenge for future research.
A third limitation concerns the degree to which the application 
of TF-CBT in this study may represent the usual clinical contexts. 
Stewart and Chambless (2009) have proposed some criteria and 
numerical assessments ranging from 0 to 9 to assess the degree of 
clinical representativeness of a study, in which this study scored 
6.5, which is higher than the theoretical mean of the scale (4.5) 
and than the scores of the effi cacy studies (between 2 and 5.5, with 
a mean of 3.7; García-Vera et al., 2015).
Finally, nearly half of the victims were taking psychotropic 
medication. Although this is a characteristic that refl ects the 
clinical representativeness of the study (Stewart & Chambless, 
2009), the medication or its synergistic effect with TF-CBT might 
be responsible for the therapeutic benefi ts of this study. However, 
these two possibilities, especially the former, do not seem very 
plausible because, in the fi rst place, psychotropic medication 
had not produced the expected benefi ts until the victims began 
psychological treatment (despite taking them for years) and, 
secondly, no signifi cant differences were found between victims 
taking psychotropic medication and those who did not in terms 
of reduction of posttraumatic stress, depression, or anxiety 
symptomatology observed at posttreatment and at the follow-ups. 
However, future research should specifi cally examine the benefi ts 
of applying TF-CBT alone or with psychotropic medication.
Despite the above limitations, the results of this study indicate 
for the fi rst time that the treatment (TF-CBT) that has been shown 
to be effi cacious for recent victims of terrorism suffering from 
PTSD is also useful in habitual clinical practice and with long-
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term benefi cial effects in victims of terrorism suffering, isolatedly 
or comorbidly, from PTSD, depressive disorders, and/or anxiety 
disorders many years after the attacks.
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